Feb 08–11, 2027 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Christina Woo, William Forrester, and Alessio Ciulli
-
Scientific Organizers: Christina Woo, William Forrester, and Alessio Ciulli
Christina Woo, PhD
Harvard University
William Forrester, PhD
Novartis
Alessio Ciulli, PhD
University of Dundee, School of Life Sciences
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, February 8, 2027
Tuesday, February 9, 2027
Neurodegenerative Targets in TPD
Solving Big Problems with Small Molecule Degraders
The Novartis Targeted Protein Degradation Platform
Clinical Development of Nurix’s Degrader Drugs
Methyl Arginine TACs
Shuttle Proteins
Pervasive Mislocalization of Pathogenic Coding Variants Underlying Human Disorders: Cell
Wednesday, February 10, 2027
Haven't Got a Glue: Protein Surface Variation for the Design of Molecular Glue Degraders
E3 Ligase and Degrader Discovery
Recognition and Removal of Proteins with Weird Stuff Attached to Them
Probing Cereblon Allosterically
Trivalent TAC Chemistry
A Pharmacological Modality to Sequester Homomeric Proteins
Chemical Immunology and Proteomics for Small Molecule Degraders
Thursday, February 11, 2027
Cell Surface Induced Proximity Engineering
Degrader Delivery through CD36
Delving into Novel Design and Development to Strive for Next-Generation ADCs Providing Long-Term Benefit to Patients
PP Interface
There is more than one Ligase and Molecular Glue for each Target... & we know Them
Future of PPIs
Friday, February 12, 2027
Subscribe for Updates